[Somatostatin in active psoriatic arthritis]

Area of Science:

• Rheumatology
• Pharmacology

Context:

• Psoriatic arthritis is a chronic inflammatory condition affecting joints and skin.
• Current treatments for psoriatic arthritis have limitations.

Purpose:

• To evaluate the therapeutic effect of a two-day continuous infusion of Somatostatin in patients with psoriatic arthritis.

Summary:

• A pilot study involving 8 patients with psoriatic arthritis assessed Somatostatin infusion.
• Five patients experienced significant clinical improvement within three weeks.
• Three patients showed no remarkable response to the treatment.

Impact:

• These preliminary findings support further investigation into Somatostatin as a potential treatment for psoriatic arthritis.
• The study highlights the need for personalized treatment approaches in psoriatic arthritis management.